Medthority.com

Chronic Kidney Disease Learning Zone medthority.com

WebChronic kidney disease (CKD) is a leading cause of mortality and morbidity that can lead to needing haemodialysis and kidney transplant. Join Professor Hiddo …

Actived: 2 days ago

URL: https://www.medthority.com/medical-education/chronic-kidney-disease-learning-zone/

Health Canada approves Trodelvy for locally advanced or …

WebGilead Sciences, Inc. announced that Health Canada has approved Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with unresectable locally …

Category:  Health Go Health

Opsynvi becomes the first and only Health Canada-approved once …

WebThe Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada approved Opsynvi (macitentan 10mg and tadalafil 40mg) for the …

Category:  Health Go Health

Twice-yearly lenacapavir demonstrates sustained impact on health

WebThese latest findings underscore the role of lenacapavir, the first long-acting injectable HIV treatment medication administered twice-yearly, as a person-centric …

Category:  Health Go Health

Personalised to Support Your Treatment Decisions Medthority

WebMedthority is an online source of credible and independent scientific content intended for healthcare professionals.

Category:  Health Go Health

Health Canada approves Arexvy to prevent respiratory syncytial …

WebHealth Canada has granted approval for GSK’s Arexvy vaccine to prevent respiratory syncytial virus (RSV)-related lower respiratory tract disease (LRTD) in people …

Category:  Health Go Health

FDA accepts for priority review the BLA for PF 06928316 (or …

WebPfizer Inc. has announced that the FDA accepted for priority review a Biologics License Application (BLA) for its respiratory syncytial virus (RSV) vaccine …

Category:  Health Go Health

Amgen announces cardiovascular study to evaluate the …

WebASCVD is defined as the buildup of cholesterol plaque in arteries and includes events such as heart attack and stroke. The African American Heart Study: is a …

Category:  Health Go Health

AstraZeneca launches Evinova a provider of digital health solutions.

WebThe Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and …

Category:  Medical Go Health

Health Canada approves Keytruda for adjuvant treatment of stage …

WebMerck Inc. announced that Health Canada has granted approval for Keytruda (pembrolizumab), Merck's anti-PD-1 therapy, for the adjuvant treatment of adult …

Category:  Health Go Health

Baxter highlights new data indicating Sharesource Digital Health

WebBaxter International Inc. a global innovator in renal care,announced new data showing kidney patients may experience a survival rate nearly two-times higher and a …

Category:  Health Go Health

New clinical data on Rayaldee (ER calcifediol) presented at Kidney …

WebOPKO Health, Inc. presented late-breaking clinical data on Rayaldee extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney …

Category:  Health Go Health

Merck/Organon to acquire Alydia Health and with it Jade System …

WebMerck and Alydia Health announced that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will …

Category:  Health Go Health

Health Canada approves AVT 04 a biosimilar to Stelara …

WebPublished: 15th Nov 2023. Alvotech and JAMP Pharma Group, a Canadian owned pharmaceutical organization headquartered in the Greater Montreal area, announced …

Category:  Health Go Health

3M spins off Solventum as an independent healthcare company

Web3M has announced Solventum will be the name of the planned, independent health care company following its spin-off. The new name and branding will go into …

Category:  Health Go Health

Novan to acquire dermatology company EPI Health

WebNovan, Inc. announced its acquisition of EPI Health, LLC (“EPI Health”), a specialty pharmaceutical company focused on the U.S. dermatology market. “As we …

Category:  Health Go Health

Top-line results from Phase III OASIS 1 and OASIS 2 studies of

WebElinzanetant successfully met all four primary endpoints in both studies demonstrating statistically significant reductions in the frequency and severity of …

Category:  Health Go Health